You are here: vision-research.eu » People » Research Groups » United Kingdom » Scanlon, Peter

Gloucestershire Diabetic Retinopathy Research Group

This research group aims to reduce the risk of sight loss among people with diabetes by the prompt Identification and effective treatment of sight threatening retinopathy. Identification involves systematic screening using digital photography and image grading to view and monitor changes occurring within the retina. Treatment might involve the application of lasers and/or different drug regimes.

Methodology

Studies involve a combination of patient questionnaires and  interviews, data collection / extraction and statistical analysis, patient information transfer and collation, and clinical trials.

Scientific Cooperations

  • Cooperation 1:
    University of Warwick
  • Cooperation 2:
    University of Oxford
  • Cooperation 3:
    European Network of Clinical Research in Ophthalmology
  • Cooperation 4:
    Royal College of Ophthalmologists
  • Cooperation 5:
    Pfizer Ltd.

Group Leader

Peter Scanlon
[more information]

Contact

Gloucestershire Hospitals NHS Foundation Trust

Cheltenham General Hospital

Sandford Road
GL53 7AN
Cheltenham, Gloucestershire
United Kingdom

Phone: (44) 08454 222 851
Fax: (44) 08454 223 853

E-mail:
peter.scanlon[at]glos.nhs.uk

Current Research Projects

  • Project 1
    FLURRI - Understanding factors leading to low uptake of diabetic retinopathy screening in primary care.
  • Project 2
    Development of a cost-effectiveness model for optimization of the screening interval in diabetic retinopathy screening.
  • Project 3
    EUROCONDOR – European Consortium for the early treatment of diabetic retinopathy using eye drops of neuroprotective drugs.
  • Project 4
    GP2DRS – General practice to diabetic retinopathy screening programme information transfer system development.
  • Project 5
    NOD – National Ophthalmology Database development.

Research Groups

People

Related Research Groups

clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology
Oops, an error occurred! Code: 20190426044210e33e358c
clinical (human) or epidemiologic studies: health care delivery/economics/manpower
Oops, an error occurred! Code: 201904260442101b2dd7bd
clinical (human) or epidemiologic studies: prevalence/incidence
Oops, an error occurred! Code: 2019042604421076aee2ba
clinical (human) or epidemiologic studies: risk factor assessment
Oops, an error occurred! Code: 201904260442105d123d68
clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials
Oops, an error occurred! Code: 201904260442106a88e073
diabetic retinopathy
Oops, an error occurred! Code: 20190426044210e2e984a4
imaging/image analysis: clinical
Oops, an error occurred! Code: 20190426044210ca61c7b1
macula/fovea
Oops, an error occurred! Code: 2019042604421083f74938
neuroprotection
Oops, an error occurred! Code: 2019042604421098954708
retinal neovascularization
Oops, an error occurred! Code: 20190426044210188c4379
eye screening
Oops, an error occurred! Code: 20190426044210a8522b83
laser treatment
Oops, an error occurred! Code: 20190426044210dae9ae69
medical retina
Oops, an error occurred! Code: 20190426044210cc0b303b
screening epidemiology
Oops, an error occurred! Code: 20190426044210a8417101